Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Dräger, S.; von Rotz, M.; Labhardt, N. D.; Siegemund, M.; Rentsch, K. M.; Osthoff, M.; Franzeck, F. C.
2023
Early target attainment with continuous infusion meropenem and piperacillin/tazobactam and utilization of therapeutic drug monitoring in critically ill patients: a retrospective cohort study from 2017 to 2020
Labhardt, N. D.; González Fernández, L.; Katende, B.; Muhairwe, J.; Bresser, M.; Amstutz, A.; Glass, T. R.; Ruhwald, M.; Sacks, J. A.; Escadafal, C.; Mareka, M.; Mooko, S. M.; de Vos, M.; Reither, K.
2023
Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho
Community-based care models for arterial hypertension management in non-pregnant adults in sub-Saharan Africa: a literature scoping review and framework for designing chronic services
Bruno, J.; Ragozzino, S.; Quitt, J.; Siegemund, M.; Labhardt, N.
2022
Severe acute respiratory syndrome coronavirus 2, primary varicella zoster virus coinfection, and a polymicrobial ventilator-associated tracheobronchitis in an adult immunocompetent male: a case report
Brown, J. A.; Nsakala, B. L.; Mokhele, K.; Rakuoane, I.; Muhairwe, J.; Glass, T. R.; Amstutz, A.; Tschumi, N.; Belus, J. M.; Klimkait, T.; Labhardt, N. D.
2022
Dolutegravir in real life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho
Tschumi, N.; Lerotholi, M.; Kopo, M.; Kao, M.; Lukau, B.; Nsakala, B.; Chejane, N.; Motaboli, L.; Lee, T.; Barnabas, R.; Shapiro, A. E.; van Heerden, A.; Lejone, T. I.; Amstutz, A.; Brown, J. A.; Heitner, J.; Belus, J. M.; Chammartin, F.; Labhardt, N. D.
2022
Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): study protocol of a cluster-randomized trial
Mapesi, H.; Gupta, R.; Wilson, H. I.; Lukau, B.; Amstutz, A.; Lyimo, A.; Muhairwe, J.; Senkoro, E.; Byakuzana, T.; Mphunyane, M.; Bresser, M.; Glass, T. R.; Lambiris, M.; Fink, G.; Gingo, W.; Battegay, M.; Paris, D. H.; Rohacek, M.; Vanobberghen, F.; Labhardt, N. D.; Burkard, T.; Weisser, M.
2021
The coArtHA trial-identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial
Amstutz, A.; Lejone, T. I.; Khesa, L.; Kopo, M.; Kao, M.; Muhairwe, J.; Bresser, M.; Räber, F.; Klimkait, T.; Battegay, M.; Glass, T. R.; Labhardt, N. D.
2021
Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: the VIBRA cluster-randomized clinical trial
Brown, J. A.; Mbunkah, H. A.; Lejone, T. I.; Ringera, I.; Cheleboi, M.; Klimkait, T.; Metzner, K. J.; Gunthard, H. F.; Labhardt, N. D.; Kouyos, R. D.; Tschumi, N.
2021
Emergence of human immunodeficiency virus-1 drug resistance during the 3-month World Health Organization-recommended enhanced adherence counseling period in the CART-1 cohort study
Labhardt, N. D.; Smit, M.; Petignat, I.; Perneger, T.; Marinosci, A.; Ustero, P.; Diniz Ribeiro, M. P.; Ragozzino, S.; Nicoletti, G. J.; Faré, P. B.; Andrey, D. O.; Jacquerioz, F.; Lebowitz, D.; Agoritsas, T.; Meyer, B.; Spechbach, H.; Salamun, J.; Guessous, I.; Chappuis, F.; Kaiser, L.; Decosterd, L. A.; Grinsztejn, B.; Bernasconi, E.; Cardoso, S. W.; Calmy, A.; Team, Ftcs
2021
Post-exposure lopinavir-ritonavir prophylaxis versus surveillance for individuals exposed to SARS-CoV-2: the COPEP pragmatic open-label, cluster randomized trial